SEC Form 4 · accession 0001209191-18-046335
TEVA PHARMACEUTICAL INDUSTRIES LTD · TEVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Iris Beck Codner
Officer — EVP Global Brand&Communication
Period of report
Aug 9, 2018
Accepted (ET)
Aug 13, 2018 · 8:34 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818686
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Aug 9, 2018 | S | 4,165 | $22.699 | D | 8,290 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Ordinary Shares were sold in New Israeli Shekels. The price shown is calculated based on the exchange rate of NIS 3.683 per $1.00, as published by the Bank of Israel on August 9, 2018.